Progressive multifocal leucoencephalopathy isolated to the brainstem and cerebellum
- 20 March 2024
- journal article
- research article
- Published by BMJ in Practical Neurology
- Vol. 24 (4) , 335-337
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- T cell deficiencies as a common risk factor for drug associated progressive multifocal leukoencephalopathyImmunobiology, 2018
- Outcome and survival of asymptomatic PML in natalizumab‐treated MS patientsAnnals of Clinical and Translational Neurology, 2014
- Diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy using MRICurrent Opinion in Neurology, 2014
- Unusual natalizumab-associated progressive multifocal leukoencephalopathy starting in the brainstemJournal of Neurology, 2013
- NatalizumabJAMA Neurology, 2013
- Risk of Natalizumab-Associated Progressive Multifocal LeukoencephalopathyNew England Journal of Medicine, 2012
- Progressive multifocal leukoencephalopathy and other forms of JC virus diseaseNature Reviews Neurology, 2010